WiCON | Pharma China (Web Edition)

ONLINE ENQUIRY

WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com

WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com

China Releases Updated NRDL and First Commercial Insurance Innovative Drug Lis... China announced on December 7 the release of an updated National Reimbursement Drug List (NRDL) and the country's first Commercial Insurance Innovative Drug List, marking...
(12/8/2025)

IQVIA Report Highlights Rising Use and Intensi... (3/25/2026)

Global Pharma Ramps Up China Investment as 15t... (3/24/2026)

US Reshoring Push Clouds Long-Term Outlook for... (3/17/2026)

China to Grant Market and Data Exclusivity for... (3/17/2026)

China Private Biotech Financing Slows in Febru... (3/13/2026)

China's Labs Race for the Next First-in-Class ... (3/12/2026)

China Challenges High-Priced Gene Therapies wi... (3/10/2026)

China Biotech Dealmaking Defies Seasonal Slowd... (3/10/2026)

US Weighs Policy Measures to Address China Bio... (3/10/2026)

China Biotech Financing Rebounds in Early 2026... (3/9/2026)

China Biotech Outlicensing Surges Past US$52 B... (3/4/2026)

2026 Biotech Playbook: Hong Kong at the Centre... (3/2/2026)

Recent Executive Moves (3/27/2026) SK Biopharma Launches Epilepsy Drug Ceno... (3/27/2026) GSK Partners Shanghai Pharma to Reintrod... (3/27/2026) Jiangsu Aidea Targets Hong Kong IPO to A... (3/27/2026) China Pharma Market Set for Structural S... (3/27/2026) Insilico and Tenacia Expand AI-Driven C... (3/27/2026) CStone Reports Promising Clinical Progre... (3/27/2026) Pinnacle Medicines Secures $89M Series B... (3/27/2026) Kelun-Biotech Secures IND Approval for S... (3/26/2026) China Issues New Guidelines to Standardi... (3/26/2026) CSPC Reports Promising Phase 1 Data for ... (3/26/2026) Novo Nordisk 'Triple-G' Diabetes Candida... (3/26/2026) Innovent Eyes China Approval as IBI302 M... (3/25/2026) China Seeks Public Input on Accelerating... (3/25/2026) China Suspends Imports of Select Indian ... (3/25/2026) BrightGene Reports Positive Phase 1 Data... (3/25/2026) Castalysis Secures Pre-A Funding to Adva... (3/25/2026) Cellgenes Raises CNY 100M+ Pre-C to Adva... (3/25/2026)

China Pharma Market Set for Structural Shift as Innovat... China Pharmaceutical Market Projected to Reach US$573B ... China's Vaccine Exports Jump More Than 50% in 2025 as O... China's Vaccine Market Set for Slow but Steady Growth T... China Companion Animal Health Market to Reach US$ 3.7B ...

Pinnacle Medicines Secures $89M Series B to Advance Ora... Insilico and Tenacia Expand AI-Driven Collaboration in... Jiangsu Aidea Targets Hong Kong IPO to Accelerate Globa... GSK Partners Shanghai Pharma to Reintroduce Hepatitis B... SK Biopharma Launches Epilepsy Drug Cenobamate in China

China Issues New Guidelines to Standardize Pharmaceutic... China Suspends Imports of Select Indian APIs Over GMP V... China Seeks Public Input on Accelerating National Drug ... CDE Seeks Comment on Draft Guideline for Advancing Onco... CDE Issues Guideline on Dose Extrapolation for Neonates...

China Issues New Policy to Strengthen Primary Healthcar... New NHSA Report Highlights Expanding Coverage and Refor... NHSA: China Medical Insurance Revenue Growth Outpaces S... China's Average Life Expectancy Hits 79.25 Years in 202... China's Tech Giants Pour Billions Into AI Healthcare Am...

U.S. ITC to Probe China's Trade Status and Biotech Prac... China Schedules Antitrust Hearing in Abuse‑of‑Dominan... Pentagon Reverses Decision After Briefly Listing WuXi A... China Indicts AstraZeneca and Former China Head Leon Wa... Roche and Henlius–Organon Resolve U.S. Patent Dispute ...

India Still Relies Heavily on China for Essential Pharm... Hybio Wins CNY 180M GLP-1 API Order as Novo Nordisk See... Abraham Accords Partners Could Help the U.S. Reduce Pha... PhIIC Report Highlights China's API Industry Rebound as... India and China Explore Reverse-Trade Model for Pharmac...

CStone Reports Promising Clinical Progress for Trispeci... Novo Nordisk 'Triple-G' Diabetes Candidate Advances to ... CSPC Reports Promising Phase 1 Data for B7-H3 ADC SYS60... Kelun-Biotech Secures IND Approval for SKB-103 in Advan... Hope Medicine Advances HMI-115 Into Phase III for Endom...

BioAtla and BeiGene Revise Global Deal for Novel Condit... Pfizer to Absorb Mylan, Creating Global Generic Powerho... PhRMA Calls for Trade Deals That Force Countries to Pay... IQVIA: Global Pharma to Grow Slower in the Next Five Ye... Pfizer and GSK Announce JV to Create a Global Consumer ...

Recent Executive Moves Recent Executive Moves Recent Executive Moves Recent Executive Moves Recent Executive Moves

China Introduces Plan for Pudong New Area's Pilot Compr... Upcoming Event: 2023 Pharma CI USA Conference & Exhibit... Upcoming Event: 15th Annual Pharma Market Research Conf... Upcoming Event: 6th International Conference on Emergin... Upcoming Event: PHARM Connect Congress

Pharma China is the most influential English media and source of business intelligence covering the Chinese pharmaceutical and biopharmaceutical sector...

WiCON has been helping international healthcare companies succeed in China and other Asian markets since 1991. We advise our clients on every stage of their China and Asian business. We worked with clients in many regions of the world...

2023 Order Form + Product Descripti... WiCON Publishes the China Pharmaceu... WiCON Publishes the China Pharmaceu... WiCON Publishes the China Pharmaceu... WiCON Publishes the China Pharmaceu...